Last updated on July 2019

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients


Brief description of study

The main purpose of the study is to investigate whether nilotinib treatment can be safely suspended with no recurrence of CML in selected patients who responded optimally on this treatment

Clinical Study Identifier: NCT01784068

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.